Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex
April 02, 2014 at 08:32 AM EDT
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced that the European Medicines Agency ("EMA") has determined ...